18.1 million. That’s the total number of new cancer cases per year expected worldwide in 2018. In Europe specifically, the number of people who will be diagnosed with cancer this year is roughly 4.2 million.
The potential for immunotherapy to transform the lives of people with cancer is vast – and the mountain of data continues to grow. But no matter how effective it may be in fighting certain cancers, it is not – and should not be – the only approach.
In oncology, patients don’t just inspire innovation. They drive it. By its very nature, precision medicine – the cutting edge of oncology – focuses our efforts on people with distinct underlying biological characteristics.
From Nobel laureates to visionary leaders to fearless patient advocates, the global oncology community has no shortage of trailblazers focused on fighting cancer. But we all know that creating truly transformative treatments and realizing the promise of precision medicine takes more than the...
In the United States and many other high income countries, the story of cancer is one of progress and hope. Over the past approximately two decades, thanks to early detection, research, new treatment and patient empowerment, the death rate from cancer in the U.S. has declined about 25 percent.
Along with the pace of medical advances in treating cancer, the cost of treating cancer has increased significantly in the last 20 years. And, because of a number of interrelated, health system-wide factors, patients disproportionately shoulder this cost.
We’re innovating rapidly and aiming to translate scientific breakthroughs into clinical benefit for as many patients as possible across a wide range of cancers. We’re focusing our efforts in the areas where we believe we can make the biggest impact.
Thanks to developments in immuno-oncology, new targeted therapies and novel combinations, cancer research is experiencing a golden era of innovation. We’re making progress toward our goal of curing this very complex disease, and the community’s optimism about the future is palpable.
Contrary to its singular name, cancer is a complex, dynamic and relentless disease. Like the Hydra of Greek mythology, cancer is a monster with many heads. And just like Hercules couldn’t vanquish the Hydra on his own, neither will we be able to cure cancer with a single drug.